Combination provides greater benefit than nivolumab alone for progression-free survival in untreated metastatic or unresectable melanoma
Antibiotic Choices for Skin, Soft Tissue Infections Vary by Race
Compared with White inpatients, Black inpatients less likely to receive cefazolin, more likely to receive clindamycin for SSTIs
Atopic Dermatitis Exacerbations Seen in Premenstrual Period
Worsening reported in eczema area and severity index score, numerical rating scale worst itch, and dermatology life quality index
Physicians Lack Knowledge About Responsibilities Under ADA
71.2 percent of the physicians answered incorrectly about who determined reasonable accommodations for patients with disability
Israel Will Give Fourth COVID-19 Shot to People Older Than 60, Health Workers
About 60 percent of Israel’s 9.4 million people are fully vaccinated with either a recent second dose or booster dose
Global Burden of Cancer Increasing
From 2010 to 2019, largest percentage increase in numbers of cases and deaths occurred in low and middle-low SDI quintiles
High-Fiber Diet May Benefit Melanoma Patients on Immunotherapy
Higher intake of dietary fiber linked to longer progression-free survival in melanoma patients on immune checkpoint blockade
Spesolimab Clears Lesions in Generalized Pustular Psoriasis
In phase 2 trial, spesolimab cleared more lesions than placebo, but it was associated with infections, systemic drug reactions
AI Allows Automated Scoring of Psoriasis Area, Severity
Convolutional neural networks have the potential to automatically perform image-based Psoriasis Area and Severity Index scoring
13 Million Adults Delaying or Skipping Meds Due to Costs
Drug unaffordability is an issue regardless of insurance status and across private, public payers